Anúncio
Anúncio
CDTX
Cidara Therapeutics, Inc.
220.90
USDPatrocinado
+0.10
+0.05%
31 de dez., 15:59 UTC -5
Encerrado
Pós-Mercado
220.90
0.00
0.00%
Relatórios de Lucros CDTX
Rácio de surpresa positiva
CDTX separação 22 de 40 últimas estimativas.
55%
Próximo Relatório
Data do Próximo Relatório
04 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$1.53
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-50.65%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-71.51%
Cidara Therapeutics, Inc. earnings per share and revenue
On 06 de nov. de 2025, CDTX reported earnings of -3.10 USD per share (EPS) for Q3 25, missing the estimate of -1.37 USD, resulting in a -125.80% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.83% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analistas forecast an EPS of -1.53 USD, with revenue projected to reach -- USD, implying an diminuir of -50.65% EPS, and aumentar of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Cidara Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Cidara Therapeutics, Inc. reported EPS of -$3.10, missing estimates by -125.8%, and revenue of $0.00, 0% as expectations.
How did the market react to Cidara Therapeutics, Inc.'s Q3 2025 earnings?
The stock price moved up 5.83%, changed from $98.64 before the earnings release to $104.39 the day after.
When is Cidara Therapeutics, Inc. expected to report next?
The next earning report is scheduled for 04 de mar. de 2026.
What are the forecasts for Cidara Therapeutics, Inc.'s next earnings report?
Based on 10
analistas, Cidara Therapeutics, Inc. is expected to report EPS of -$1.53 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio